- cafead Sep 09, 2021 at 11:32: AM
via Amid the global shortage of Lupron, used to treat pain associated with cancer, AbbVie took its partner Takeda to court over alleged failures to live up to supply agreements. Now, a court has denied the company's plea to force Takeda to fill orders.
In an opinion this week, Delaware Chancery Court Vice Chancellor Sam Glasscock III denied AbbVie's request to compel Takeda to fill supply orders from its plant in Hikari, Japan.
article source
In an opinion this week, Delaware Chancery Court Vice Chancellor Sam Glasscock III denied AbbVie's request to compel Takeda to fill supply orders from its plant in Hikari, Japan.
article source